Andrew Park
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Andrew Park has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Benjamin F. Chong
Department of Dermatology University of Texas Southwestern Medical Center Dallas Texas USA
1 shared publication - Chae Gyu Park
Laboratory of Immunology, Severance Biomedical Science Institute, Yonsei University College of Medicine
1 shared publication - Julianne A. Mann
Section of Dermatology, Department of Surgery Dartmouth‐Hitchcock Medical Center Lebanon New Hampshire USA
1 shared publication - Peter K. Olds
Massachusetts General Hospital
1 shared publication Ralph M. Steinman
Laboratory of Cellular Physiology and Immunology, Chris Browne Center for Immunology and Immune Disease, The Rockefeller University, New York, NY, 10065, United States of America
1 shared publicationRasika Reddy
Department of Dermatology University of Texas Southwestern Medical Center Dallas Texas USA
1 shared publication
Latest Publications
- Open Access
- 18 October 2022
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 35 (12)
Concomitant nondermatologic adverse events in patients who develop immunotherapy‐induced subacute cutaneous lupus erythematosus
- 18 October 2022
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 35 (12)
Open AccessConcomitant nondermatologic adverse events in patients who develop immunotherapy‐induced subacute cutaneous lupus erythematosus
- 10 May 2018
- Published by Wiley in Pediatric Dermatology
- Vol. 35 (3) , 406-407
Twelve‐year‐old boy with multiple waffle‐like purpuric patches
- 10 May 2018
- Published by Wiley in Pediatric Dermatology
- Vol. 35 (3) , 406-407
Twelve‐year‐old boy with multiple waffle‐like purpuric patches
- Open Access
- 8 January 2016
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (1) , e0146412
Dendritic Cells Induce a Subpopulation of IL-12Rβ2-Expressing Treg that Specifically Consumes IL-12 to Control Th1 Responses
Cytokines secreted from dendritic cells (DCs) play an important role in the regulation of T helper (Th) cell differentiation and activation into effector cells. Therefore, controlling cytokine secretion from DCs may potentially regulate Th differentiation/activation. DCs also induce de-novo generation of regulatory T cells (Treg) that modulate the immune response. In the current study we used the mixed leukocyte reaction (MLR) to investigate the effect of allospecific Treg on IL-12, TNFα and IL-6 secretion by DCs. Treg cells were found to markedly down-regulate IL-12 secretion from DCs following stimulation with TLR7/8 agonist. This down-regulation of IL-12 was neither due to a direct suppression of its production by the DCs nor a result of marked DC death. We found that IL-12 was rather actively consumed by Treg cells. IL-12 consumption was mediated by a subpopulation of IL-12Rβ2-expressing Treg cells and was dependent on MHC class-II expressed on dendritic cells. Furthermore, IL-12 consumption by Tregs increased their suppressive effect on T cell proliferation and Th1 activation. These results provide a new pathway of Th1 response regulation where IL-12 secreted by DCs is consumed by a sub-population of IL-12Rβ2-expressing Treg cells. Consumption of IL-12 by Tregs not only reduces the availability of IL-12 to Th effector cells but also enhances the Treg immunosuppressive effect. This DC-induced IL-12Rβ2-expressing Treg subpopulation may have a therapeutic advantage in suppressing Th1 mediated autoimmunity.
- 8 January 2016
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (1) , e0146412
Open AccessDendritic Cells Induce a Subpopulation of IL-12Rβ2-Expressing Treg that Specifically Consumes IL-12 to Control Th1 Responses
Cytokines secreted from dendritic cells (DCs) play an important role in the regulation of T helper (Th) cell differentiation and activation into effector cells. Therefore, controlling cytokine secretion from DCs may potentially regulate Th differentiation/activation. DCs also induce de-novo generation of regulatory T cells (Treg) that modulate the immune response. In the current study we used the mixed leukocyte reaction (MLR) to investigate the effect of allospecific Treg on IL-12, TNFα and IL-6 secretion by DCs. Treg cells were found to markedly down-regulate IL-12 secretion from DCs following stimulation with TLR7/8 agonist. This down-regulation of IL-12 was neither due to a direct suppression of its production by the DCs nor a result of marked DC death. We found that IL-12 was rather actively consumed by Treg cells. IL-12 consumption was mediated by a subpopulation of IL-12Rβ2-expressing Treg cells and was dependent on MHC class-II expressed on dendritic cells. Furthermore, IL-12 consumption by Tregs increased their suppressive effect on T cell proliferation and Th1 activation. These results provide a new pathway of Th1 response regulation where IL-12 secreted by DCs is consumed by a sub-population of IL-12Rβ2-expressing Treg cells. Consumption of IL-12 by Tregs not only reduces the availability of IL-12 to Th effector cells but also enhances the Treg immunosuppressive effect. This DC-induced IL-12Rβ2-expressing Treg subpopulation may have a therapeutic advantage in suppressing Th1 mediated autoimmunity.